Oxidative Damage in Murine Tumor Cells Treated in Vitro by Recombinant Human Tumor Necrosis Factor

Cancer Research

Volumn 49, Issue 7, 1989, Pages 1644-1648

  Zimmerman, Robert J ^a   Chan, Anthony ^a   Leadon, Steven A ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; CELL CULTURE; CYTOTOXICITY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; TUMOR CELL;

ANIMAL; DNA DAMAGE; DRUG RESISTANCE; GLUTATHIONE; HYDROGEN PEROXIDE; MICE; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THYMINE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0024582830     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Haranka, K., and Satomi, N. Cytotoxic activity of tumor necrosis factor on human cancer cells in vitro. Jpn. J. Exp. Med., 51:191-194,1981.
2. Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., and Shepard, H. M. Recombinant human tumor necrosis factor-alpha effects on proliferation of normal and transformed cells in vitro. Science (Wash. DC), 230: 943-945, 1985.
3. Creasey, A. A., Doyle, L. V., Reynolds, M. T., Jung, T., Lin, L. S., and Vitt, C. R. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res., 47: 145-149, 1987.
4. Kull, F. C., Jr., Jacobs, S., and Cuatrecasas, P. Cellular receptor for, 25 I-labeled tumor necrosis factor specific binding, affinity labeling, and relationship to sensitivity. Proc. Natl. Acad. Sci. USA, 82:5756-5760,1985.
5. Tsujimoto, M., Yip, Y. K., and Vilcek, J. Tumor necrosis factor specific binding and internalization in sensitive and resistant cells. Proc. Natl. Acad. Sci. USA, 82:7626-7630,1985.
6. Zimmerman, R. J., Marafino, B. J., Chan, A., Landre, P., and Winkelhake, J. L. The role of free radicals in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo: implications for mechanisms of action. J. Immunol., in press, 1989.
7. Meister, A. Selective modification of glutathione metabolism. Science (Wash. DC), 220:472-477,1983.
8. Leadon, S. A. Production of thymine glycols in DNA by radiation and chemical carcinogens as detected by a monoclonal antibody. Br. J. Cancer, 55:113-117,1987.
9. Leadon, S. A., and Kaneko, M. Production of thymine glycols by JV-hydroxy-2-naphthylamine as detected by a monoclonal antibody. Cancer Res., 46:71-75,1986.
10. Leadon, S. A., Stampfer, M. R., and Bartley, J. Production of oxidative DNA damage during the metabolic activation of benzo(a)pyrene in human mammary epithelial cells correlates with cell killing. Proc. Natl. Acad. Sci. USA, 85:4365-4368,1988.
11. Wang, A. M., Creasey, A. A., Ladner, M. B., Lin, L. S., Strickler, J., Van Arsdell, J. N., Yamamoto, R., and Mark, D. F. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science (Wash. DC), 228:149-154,1985.
12. Griffith, O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem., 106: 207-212, 1980.
13. Leadon, S. A., and Hanawalt, P. C. Monoclonal antibody to DNA containing thymine glycol. Mutat. Res., 122:191-200,1983.
14. Beer, M., Stern, S., Carmalt, D., and Mohlenrich, K. H. Determination of base sequence in nucleic acids with the electron microscope. V. The thymine-specific reactions of osmium tetroxide with deoxyribonucleic acid and its components. Biochemistry, 5:2283-2288,1966.
15. Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finlde, B. S., and Palladino, M. A., Jr. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J. Immunol., 135:2069-2073,1985.
16. Klebanoff, S. J., Vadas, M. A., Harlan, J. M., Sparks, L. H., Gamble, J. R., Agosti, J. M., and Waltersdorph, A. M. Stimulation of neutrophils by tumor necrosis factor. J. Immunol., 136:4220-4225,1986.
17. Tsujimoto, M., Yokota, S., Vilcek, J., and Wiessmann, G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem. Biophys. Res. Commun., 137:1094-1100,1986.
18. Berkow, R. L., Wang, D., Larrick, J. W., Dodson, R. W., and Howard, T. H. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J. Immunol., 139: 3783-3791, 1987.
19. Talmadge, J. E., Tribble, H. R., Pennington, R. W., Phillips, H., and Wiltrout, R. H. Immunomodulatory and immunotherapeutic properties of recombinant γ-interferon and recombinant tumor necrosis factor in mice. Cancer Res., 47:2563-2570,1987.
20. Talmadge, J. E., Phillips, H., Schneider, M., Rowe, T., Pennington, R., Bowersox, O., and Lenz, B. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res., 48:544-550,1988.
21. Watanabe, N., Niitsu, Y., Neda, H., Sone, H., Yamauchi, N., Maeda, M., and Urushizaki, I. Cytocidal mechanism of TNF effects of lysosomal enzyme and hydroxyl radical inhibition on cytotoxicity. Immunopharmacol. Immu-notoxicol., 10:109-116,1988.
22. Matthews, N., Neale, M. L., Jackson, S. K., and Stark, J. M. Tumor cell killing by tumor necrosis factor: inhibition by anaerobic conditions, free radical scavengers, and inhibitors of arachidonate metabolism. Immunology, 62:153-155,1987.
23. Wong, G. H. W., and Goeddel, D. V. Induction of manganous superoxide dismutase by tumor necrosis factor possible protective mechanism. Science (Wash. DC), 242:941-944,1988.
24. Niitsu, Y., Watanabe, N., Umeno, H., Sone, H., Neda, H., Yamauchi, N., Maeda, M., and Urushivaki, I. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis. Cancer Res., 48:654-657,1988.
25. Alexander, R. B., Isaacs, J. T., and Coffey, D. S. Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer. J. Urol, 758:427-429,1987.
26. Alexander, R. B., Nelson, W. G., and Coffey, D. S. Tumor necrosis factor synergistic enhancement of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II. Cancer Res., 47:2403-2406,1987.